Select a Region North America


headshot of Kerem Can Alp

Kerem Can Alp

Manager, Commercial Strategy



Kerem has over a decade of experience in the pharmaceutical industry, having worked in various capacities within European and US-based organizations. Throughout his career, he has held key roles in business development and strategy, focusing on Pharma, CDMO, and CSO companies.

Currently, Kerem works as a member of the Commercial Strategy team within EVERSANA, where he is responsible for EVERSANA COMPLETE Commercialization® and Integrated commercial assessments and projects in both the United States and Europe.

Kerem has an M.A. in Political Economy from the University of Chicago where he was a Fulbright Scholar.


Articles by Kerem Can Alp

Successfully Navigating Self-Commercialisation in Europe
Successfully Navigating Self-Commercialisation in Europe

Introduction As discussed in our previous paper, Successful Launches in Europe: Complex, But Not Complicated?,,  Europe is one of the world’s largest and most important regions of focus for pharmaceutical and biotechnology manufacturers looking to treat patients and maximise the value of their products. However, the challenges of entering this market, particularly in terms of […]

Read now: Successful Launches in Europe: Complex, But Not Complicated?
Successful Launches in Europe: Complex, but Not Complicated?

Europe represents a major pharmaceutical market – it accounts for 22% of the global market, second only to the U.S. in terms of market size and has a large population of over 500 million. Understandably, pharmaceutical and biotechnology companies looking to maximise their revenue consider Europe to be a key focus[1]. Indeed, looking at first-time […]

Interested in scheduling a meeting or speaking event?

Contact Us

  • This field is for validation purposes and should be left unchanged.